Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal fluticasone to prevent oxymetazoline tolerance and rebound in persistent allergic rhinitis
2007-003291-19Phase 4Terminated
- Sponsor
- University of Dundee
- Start
- Jun 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of fluticasone propionate in allergic rhinitis (AR) and rhinitis medicamentosa (RM) (2 arms), sponsored by University of Dundee. Started Jun 2009; status: terminated.
02
Drugs
fluticasone propionate
03
Conditions
allergic rhinitis (AR)rhinitis medicamentosa (RM)
Beyond the preview
Go deeper on 2007-003291-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003291-19.